bioAffinity Technologies, Inc.

Healthcare · Diagnostics & Research · United States

Last price 3.03 USD (Oct 29, 2026, 4:00 PM EDT) · Market cap 3.89M

Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports

bioAffinity Technologies, Inc. engages in developing non-invasive diagnostic laboratory tests to detect early-stage lung cancer and other diseases of the lung using flow cytometry and automated analysis in the United States. The company operates through two segments: Diagnostic Research and Development; and Laboratory Services. The company offers CyPath lung which uses flow cytometry technology to detect and analyze cell populations in a person’s sputum, or phlegm, to find characteristics indicative of lung cancer, including cancer and/or cance...